Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Type Project # RFA # PI/Project Leader Institution Title Statussort descending
2020 R43 PAR-18-303 WARREN, CHRISTOPHER L PROTEOVISTA, LLC Development Of The High Throughput Apt-snap Platform For Rapid Identification Ofnuclease-resistant Rna Aptamers Against P53 Missense Mutations Active
2019 R33 RFA-CA-18-005 LEI, YUGUO UNIVERSITY OF NEBRASKA LINCOLN A Single Conical Tube Device for Precision CAR-T Cells Manufacturing Active
2022 R33 CA21-004 PAN, TAO UNIVERSITY OF CHICAGO Transfer RNA sequencing and application to cancer research and clinics Active
2018 R21 RFA-CA-17-010 BRENT, ROGER FRED HUTCHINSON CANCER RESEARCH CENTER Precision controllers of mammalian gene expression Active
2020 R33 RFA-CA-19-020 WEI, CHIA-LIN JACKSON LABORATORY Advancing Ultra Long-read Sequencing And Chromatin Interaction Analyses For Chromosomal And Extrachromosomal Structural Variation Characterization In Cancer Active
2020 R21 RFA-CA-19-019 HUR, SOOJUNG CLAIRE JOHNS HOPKINS UNIVERSITY Development of a microfluidic primary cell editing platform (pCEP) for personal gene therapy Active
2022 R33 CA21-004 LEE, ABRAHAM P UNIVERSITY OF CALIFORNIA-IRVINE Microfluidic Precision Engineered Artificial Antigen Presenting Cells for Cancer Immunotherapy Active
2020 R44 PAR-18-303 WINTERS, IAN PAUL D2G ONCOLOGY, INC. Relating Drugs To Genotypes To Transform Precision Cancer Therapeutics With Tuba-seq - A Novel, Highly Scalable And Quantitative Preclinical Experimental Oncology Platform Active
2020 R33 RFA-CA-19-020 HALL, ADAM ROGER WAKE FOREST UNIVERSITY HEALTH SCIENCES Detecting diverse nucleic acid biomarkers of cancer with solid-state nanopores Active
2020 R21 RFA-CA-19-019 REVZIN, ALEXANDER MAYO CLINIC ROCHESTER A microfluidic cell culture platform for personalizing pancreatic cancer therapies Active
2022 R21 CA21-003 SNYDER, JOSHUA CLAIR DUKE UNIVERSITY Mouse Paint: A massively combinatorial approach for illuminating tumor heterogeneity in True Color Active
2020 R33 RFA-CA-19-020 WANG, SHAOPENG ARIZONA STATE UNIVERSITY-TEMPE CAMPUS A Virion-Display Oscillator Array and Detection Platform for Quantification of Transmembrane Protein Binding Kinetics Active
2020 R21 RFA-CA-19-019 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA High Throughput Digital Droplet ELISA for Ultrasensitive Multiplexed Diagnostics Active
2019 R21 RFA-CA-18-002 IM, HYUNGSOON MASSACHUSETTS GENERAL HOSPITAL Nano-plasmonic technology for high-throughput single exosome analyses Active
2018 R21 RFA-CA-17-010 FU, XIAO-AN UNIVERSITY OF LOUISVILLE A microreactor chip platform for quantitative analysis of unsaturated aldehydes in exhaled breath Active
2022 R21 CA21-003 GIBBS, SUMMER LYNNE OREGON HEALTH & SCIENCE UNIVERSITY A Novel Fluorescence Imaging Platform to Predict Response to Combinatorial Tyrosine Kinase Inhibitors Active
2021 R21 RFA-CA-20-019 SANTORE, MARIA M UNIVERSITY OF MASSACHUSETTS AMHERST Paper-based Breastmilk Collection System for Facile, In-Home Use Active
2020 R21 RFA-CA-19-019 CICERONE, MARCUS T GEORGIA INSTITUTE OF TECHNOLOGY Label-Free Cell-Resolved Metabolomics for Tumor Microscopy Active
2004 R21 PAR-01-106 MAITRA, ANIRBAN JOHNS HOPKINS UNIVERSITY A SEQUENCING MICROARRAY FOR MITOCHONDRIAL MUTATIONS Complete
2007 R21 RFA-CA-07-015 REICH, DANIEL H JOHNS HOPKINS UNIVERSITY MAGNETICALLY PATTERNED CO-CULTURES FOR CANCER STUDIES Complete
2010 R21 RFA-CA-09-006 TURK, BENJAMIN E YALE UNIVERSITY GLOBAL PEPTIDE MICROARRAY PROFILING OF TYROSINE KINASES DEREGULATED IN CANCER Complete
2014 R21 RFA-CA-13-001 ZAIA, JOSEPH BOSTON UNIVERSITY MEDICAL CAMPUS QUANTITATIVE PROFILING OF GLYCOSAMINOGLYCANS FROM BREAST TUMOR TISSUE ARRAYS Complete
2017 R21 RFA-CA-16-001 KESHARI, KAYVAN R. SLOAN-KETTERING INST CAN RESEARCH uCoil NMR platform for robust and high-throughput analysis of in vitro metabolic flux on living cells Complete
2001 R21 PAR-99-100 GUO, BAOCHUAN CLEVELAND STATE UNIVERSITY MALDI TOF TECHNOLOGY FOR MOLECULAR ANALYSIS OF CANCER Complete
2003 R21 PAR-01-104 MAKRIGIORGOS, G. MIKE DANA-FARBER CANCER INSTITUTE ERROR-FREE DNA AMPLIFICATION FOR MUTATION DETECTION Complete
2006 R33 RFA-CA-06-004 LANDERS, JAMES P UNIVERSITY OF VIRGINIA CHARLOTTESVILLE MICRODEVICE FOR DIRECT DNA PURIFICATION Complete
2009 R21 RFA-CA-08-007 LIU, YANG UNIVERSITY OF PITTSBURGH AT PITTSBURGH PARTIAL-WAVE SPECTROSCOPIC MICROSCOPY FOR THE DIAGNOSIS OF CHOLANGIOCARCINOMA Complete
2013 R21 RFA-CA-12-002 JEFFREY, STEFANIE S. STANFORD UNIVERSITY A DROPLET-BASED SYSTEM FOR CAPTURE, MANIPULATION, AND BIOCHEMICAL PROFILING OF RA Complete
2016 R33 RFA-CA-15-003 SPICER, TIMOTHY PATRICK SCRIPPS FLORIDA ADVANCED DEVELOPMENT AND VALIDATION OF 3 DIMENSIONAL SPHEROID CULTURE OF PRIMARY CANCER CELLS USING NANO3D TECHNOLOGY Complete
2000 R33 PAR-98-067 HUANG, TIM H.-M. UNIVERSITY OF MISSOURI-COLUMBIA HIGH THROUGHPUT METHYLATION ANALYSIS IN CANCER Complete
2002 R33 PAR-99-100 CHURCHILL, GARY A JACKSON LABORATORY EXPERIMENTAL DESIGN & ANALYSIS FOR EXPRESSION MICROARRAY Complete
2005 R43 RFA-CA-05-007 PHILIP, RAMILA IMMUNOTOPE, INC. IDENTIFICATION OF AUTO ANTIGENS IN OVARIAN CANCER Complete
2008 R43 RFA-CA-07-041 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC QUANTITATIVE PROTEOMICS OF METASTASIS Complete
2011 R33 RFA-CA-10-004 GARRAWAY, LEVI A DANA-FARBER CANCER INST HIGH-THROUGHPUT TUMOR GENOMIC PROFILING BY MASSIVELY PARALLEL SEQUENCING Complete
2015 R33 RFA-CA-14-006 BROWN, JONATHAN QUINCY TULANE UNIVERSITY OF LOUISIANA IMPROVING BIOSPECIMEN QUALITY BY VERIFYING ADEQUACY AT THE POINT-OF-ACQUISITION WITH EX VIVO STRUCTURED ILLUMINATION MICROSCOPY Complete
2000 R21 PAR-98-067 GIESE, ROGER WALLACE NORTHEASTERN UNIVERSITY CATION LABELING MASS SPECTROMETRY OF DNA ADDUCTS Complete
2002 R21 PAR-01-106 BAKER, LAURENCE HOWARD UNIVERSITY OF MICHIGAN AT ANN ARBOR MOLECULAR DIAGNOSIS OF SARCOMAS Complete
2005 R21 RFA-CA-05-002 KELLEY, SHANA O BOSTON COLLEGE NANOSCALE ELECTROCATALYTIC PROTEIN DETECTION Complete
2008 R21 RFA-CA-07-033 KELLEY, SHANA O UNIVERSITY OF TORONTO DEVELOPMENT OF DNA-TEMPLATED IR QUANTUM DOTS Complete
2011 R21 RFA-CA-10-003 EVANS, CONOR LEE MASSACHUSETTS GENERAL HOSPITAL HYPERSPECTRAL AND STRUCTURAL MICROSCOPY PLATFORM FOR THERAPY OF RESISTANT CANCER Complete
2015 R21 RFA-CA-14-003 WILLIAMS, JOHN CHARLES BECKMAN RESEARCH INSTITUTE/CITY OF HOPE IN SITU IMAGING OF CAR T-CELLS Complete
2018 R21 RFA-CA-17-010 MAILLOUX, ADAM WILLIAM H. LEE MOFFITT CANCER CTR & RES INST Autohistomagnetic Isolation of Tumor-reactive T-cells Complete
2022 R21 CA21-003 BOYLE, ALAN P UNIVERSITY OF MICHIGAN AT ANN ARBOR High-throughput inverted reporter assay for characterization of silencers and enhancer blockers Complete
1999 R21 PAR-98-067 TOLIAS, P P PUBLIC HEALTH RESEARCH INSTITUTE FUNCTIONAL CLONING OF DNA AND RNA BINDING PROTEINS Complete
2001 R33 PAR-99-102 PALLAVICINI, MARIA G. UNIVERSITY OF CALIFORNIA SAN FRANCISCO PROTEIN SIGNATURES OF LEUKEMIC CELLS Complete
2001 R33 PAR-99-102 MORRIS, DAVID R UNIVERSITY OF WASHINGTON DEVELOPMENT OF TRANSLATION STATE ARRAY ANALYSIS Complete
2004 R21 PAR-01-106 DE VERE WHITE, RALPH W. UNIVERSITY OF CALIFORNIA DAVIS YEAST ASSAY FOR P53 MOLECULAR ANALYSIS IN BLADDER CANCER Complete
2007 R21 RFA-CA-07-015 RESING, KATHERYN A UNIVERSITY OF COLORADO NEW METHODS FOR PHOSPHOPEPTIDE IDENTIFICATION Complete
2010 R21 RFA-CA-09-006 HULKOWER, KEREN ISAAC PLATYPUS TECHNOLOGIES, LLC TRANSFORMATIVE HTS CELL MIGRATION ASSAY FOR RAPID SCREENING OF CANCER THERAPEUTIC Complete
2014 R21 RFA-CA-13-001 ISSADORE, DAVID AARON UNIVERSITY OF PENNSYLVANIA A MICRO HALL CHIP FOR CIRCULATING MICROVESICLE BASED CANCER MONITORING Complete

Pages